A24G (p.Ala24Gly) variant of EGFR (Epidermal growth factor receptor)

A24G (p.Ala24Gly) in EGFR (Epidermal growth factor receptor) is a missense change. Clinical records from EBI and UniProt describe it as uncertain significance. The available variant effect predictions contribute to a CATVariant prioritization score of 0.33 / 1. The record also includes population frequency data and structural context.

A24G (p.Ala24Gly) variant details